Cynvenio Biosystems has hired Paul Song as its chief medical officer to oversee the firm's translational and clinical research programs. He will be responsible for all clinical utility activities, including trial definition, institutional partner selection, and patient stratification. He also will coordinate global activities with international partners, in particular those in Europe and China. Song is on the faculty at Cedars Sinai Medical Center and is CMO at AT-Gen. He is also a senior adviser at Berg Health.